- Patent Title: High affinity antibodies targeting tau phosphorylated at serine 413
-
Application No.: US17355529Application Date: 2021-06-23
-
Publication No.: US11702467B2Publication Date: 2023-07-18
- Inventor: Jeanne E. Baker , Sophie Parmentier Batteur , Ming-Tang Chen , Alan C. Cheng , Chung-Ming Hsieh , Carl Mieczkowski , Sokreine Suon
- Applicant: Merck Sharp & Dohme LLC
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme LLC
- Current Assignee: Merck Sharp & Dohme LLC
- Current Assignee Address: US NJ Rahway
- Agent Sanjeev K. Mahanta; Alysia A. Einnegan
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/18 ; A61P25/28 ; C07K16/06 ; C07K16/40 ; C07K16/44 ; A61P25/00 ; A61K45/06 ; A61K39/00
Abstract:
Provided herein are high affinity antibodies or antigen binding fragments thereof that specifically bind to human tau-pS413. Also provided are compositions, kits, methods, and uses involving such antibodies or antigen binding fragments thereof.
Public/Granted literature
- US20230167168A9 HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413 Public/Granted day:2023-06-01
Information query
